At a glance
- Originator Meiji Seika Kaisha
- Class Antineoplastics; Carbazoles; Indole alkaloids
- Mechanism of Action P-glycoprotein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 20 Jun 2001 No-Development-Reported for Cancer in Japan (Intraperitoneal)
- 04 Aug 1998 Profile reviewed
- 21 Feb 1996 Preclinical development for Cancer in Japan (Intraperitoneal)